Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Robert Williams, Jr. Sells 1,500,000 Shares

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Robert Williams, Jr. sold 1,500,000 shares of Aveanna Healthcare stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $9.00, for a total transaction of $13,500,000.00. Following the completion of the transaction, the insider directly owned 362,746 shares in the company, valued at $3,264,714. This trade represents a 80.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Aveanna Healthcare Price Performance

Shares of NASDAQ:AVAH opened at $9.81 on Wednesday. The company’s 50 day simple moving average is $8.60 and its 200 day simple moving average is $6.24. The stock has a market capitalization of $2.05 billion, a price-to-earnings ratio of 122.63 and a beta of 2.05. Aveanna Healthcare Holdings Inc. has a 1 year low of $3.67 and a 1 year high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Monday, May 22nd. The company reported $0.04 earnings per share (EPS) for the quarter. The business had revenue of $450.53 million for the quarter. Aveanna Healthcare had a net margin of 0.85% and a negative return on equity of 54.56%. As a group, analysts anticipate that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. Barclays raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $5.50 to $9.50 in a research note on Tuesday, August 19th. Wall Street Zen raised shares of Aveanna Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 9th. Truist Financial decreased their target price on shares of Aveanna Healthcare from $6.00 to $5.00 and set a “hold” rating on the stock in a research note on Wednesday, July 16th. Zacks Research lowered shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, October 20th. Finally, Royal Bank Of Canada lifted their price target on shares of Aveanna Healthcare from $8.00 to $10.00 and gave the stock a “sector perform” rating in a report on Friday, October 24th. Three equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $9.29.

Hedge Funds Weigh In On Aveanna Healthcare

A number of hedge funds have recently modified their holdings of the business. Rhumbline Advisers lifted its holdings in shares of Aveanna Healthcare by 4.0% during the first quarter. Rhumbline Advisers now owns 75,581 shares of the company’s stock worth $410,000 after purchasing an additional 2,918 shares during the period. MetLife Investment Management LLC lifted its holdings in Aveanna Healthcare by 16.2% in the first quarter. MetLife Investment Management LLC now owns 31,251 shares of the company’s stock valued at $169,000 after buying an additional 4,349 shares during the period. AQR Capital Management LLC lifted its holdings in Aveanna Healthcare by 21.2% in the first quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock valued at $142,000 after buying an additional 4,602 shares during the period. Bank of New York Mellon Corp lifted its holdings in Aveanna Healthcare by 4.2% in the first quarter. Bank of New York Mellon Corp now owns 114,881 shares of the company’s stock valued at $623,000 after buying an additional 4,655 shares during the period. Finally, Invesco Ltd. lifted its holdings in Aveanna Healthcare by 31.1% in the second quarter. Invesco Ltd. now owns 20,006 shares of the company’s stock valued at $105,000 after buying an additional 4,742 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.